mycosyst 50 mg capsule
gedeon richter plc - fluconazolum - capsule - 50 mg
sevpram comprimate filmate 10 mg
helba phamaceuticals inc. co. - escitalopramum - comprimate filmate - 10 mg
sevpram comprimate filmate 20 mg
helba phamaceuticals inc. co. - escitalopramum - comprimate filmate - 20 mg
fusys comprimate 100 mg
kusum healthcare pvt.ltd - fluconazolum - comprimate - 100 mg
fusys comprimate 150 mg
kusum healthcare pvt.ltd - fluconazolum - comprimate - 150 mg
fusys comprimate 200 mg
kusum healthcare pvt.ltd - fluconazolum - comprimate - 200 mg
fusys comprimate 50 mg
kusum healthcare pvt.ltd - fluconazolum - comprimate - 50 mg
posaconazol mylan 40 mg/ml
genepharm s.a. - grecia - posaconazolum - susp. orala - 40mg/ml - antimicotice de uz sistemic derivati de triazol
posaconazol mylan 40 mg/ml
genepharm s.a. - grecia - posaconazolum - susp. orala - 40mg/ml - antimicotice de uz sistemic derivati de triazol
cosentyx
novartis europharm limited - secukinumab - arthritis, psoriatic; psoriasis; spondylitis, ankylosing - imunosupresoare - plaque psoriasiscosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults and children from the age of 6 years old who are candidates for systemic therapy. hidradenitis suppurativa (hs)cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic hs therapy. psoriazică arthritiscosentyx, singur sau în asociere cu metotrexat (mtx), este indicat pentru tratamentul artritei psoriazice active la pacienții adulți, atunci când răspunsul la precedenta modificare a bolii anti-reumatice droguri (marmb) a fost terapia inadecvată. spondilartrită axială (axspa)spondilita anchilozantă (ca, radiografic spondilartrită axială)cosentyx este indicat pentru tratamentul de spondilită anchilozantă activă la adulți care au răspuns inadecvat la terapia convențională. non-radiographic axial spondyloarthritis (nr-axspa)cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) evidence in adults who have responded inadequately to non steroidal anti inflammatory drugs (nsaids). juvenile idiopathic arthritis (jia)enthesitis-related arthritis (era)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active enthesitis-related arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. juvenile psoriatic arthritis (jpsa)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.